Cite
HARVARD Citation
Garcia-Manero, G. et al. (2020). Results of a Phase 1/2a dose–escalation study of FF-10501-01, an IMPDH inhibitor, in patients with acute myeloid leukemia or myelodysplastic syndromes. Leukemia & lymphoma. 61 (8), pp. 1943-1953. [Online].